Loading Pathway...
Error: Pathway image not found.
Hide
Pathway Description
Thrombin Alfa Action Pathway
Homo sapiens
Drug Action Pathway
Thrombin alfa also known under the brand name Recothrom, is a platelet-activating factor to treat minor bleeding. It is administered topically, it is a recombinant thrombin identical to that of the endogenous human thrombin. Thrombin alfa is a human serine protease that cleaves fibrinogen to fibrin which leads to clot formation. Once thrombin alfa has performed its function it is rapidly inactivated by circulating endogenous plasma inhibitors.
References
Thrombin Alfa Pathway References
Crawley JT, Zanardelli S, Chion CK, Lane DA: The central role of thrombin in hemostasis. J Thromb Haemost. 2007 Jul;5 Suppl 1:95-101. doi: 10.1111/j.1538-7836.2007.02500.x.
Pubmed: 17635715
Rajesh Singh R, Chang JY: Structural stability of human alpha-thrombin studied by disulfide reduction and scrambling. Biochim Biophys Acta. 2003 Sep 23;1651(1-2):85-92. doi: 10.1016/s1570-9639(03)00238-3.
Pubmed: 14499592
Slezak P, Keibl C, Labahn D, Schmidbauer A, Genyk Y, Gulle H: A Comparative Efficacy Evaluation of Recombinant Topical Thrombin (RECOTHROM((R))) With A Gelatin Sponge Carrier Versus Topical Oxidized Regenerated Cellulose (TABOTAMP((R))/SURGICEL((R))) In A Porcine Liver Bleeding Model. J Invest Surg. 2021 Aug;34(8):862-868. doi: 10.1080/08941939.2019.1705444. Epub 2020 Jan 20.
Pubmed: 31955627
Highlighted elements will appear in red.
Highlight Compounds
Highlight Proteins
Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
Visualize Compound Data
Visualize Protein Data
Downloads
Settings